Form 4: Xtant Medical Holdings CEO Reports Stock Transaction
SEC Form 4 Filing
Sean E. Browne, President and CEO of Xtant Medical Holdings, reports disposition of shares to cover tax obligations.
Summary
- On October 15, 2024, Sean E. Browne, the President and CEO of Xtant Medical Holdings, Inc., reported a transaction involving the company's common stock.
- The transaction involved the disposition of 105,442 shares to cover tax withholding obligations upon the vesting and settlement of restricted stock unit awards at a price of $0.59.
- Following the transaction, Browne directly owns 2,190,942 shares of Xtant Medical Holdings, Inc.
- This includes 862,294 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon continued employment.
Sentiment
Score: 5
Explanation: This is a neutral report on a routine stock transaction related to executive compensation. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is related to tax obligations on executive compensation.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date of stock transaction (disposition of shares). |
| 10/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.